Sign up for the Today newsletter
Get everything you need to know to start your day, delivered right to your inbox every morning.
A Cambridge-based pharmaceutical company is laying off close to a hundred employees.
Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last week that it will lay off 83 employees by June 30.
Ono Pharma develops medicines across oncology, neurology, immunology, and specialty drugs.
According to the company’s U.S. website, it was founded in 1717 in Osaka, Japan.
The company has 3,853 employees internationally and a capital of 17.358 billion yen, equivalent to approximately $121.5 million, as of 2024. Besides Cambridge, the company also has subsidiaries in London, Seoul, and Taipei.
The company expanded in the U.S. in 2020 and moved its U.S. headquarters to Cambridge the following year. The company also has offices in San Francisco.
Ono Pharma did not immediately respond to a request to comment.
Ono Pharma is following several biotech companies in the state that recently announced layoffs, including Takeda Pharmaceuticals, Thermo Fisher Scientific, and Relay Therapeutics.
Beth Treffeisen is a general assignment reporter for Boston.com, focusing on local news, crime, and business in the New England region.
Get everything you need to know to start your day, delivered right to your inbox every morning.
Stay up to date with everything Boston. Receive the latest news and breaking updates, straight from our newsroom to your inbox.
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com